Crestwood Advisors Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.16M | Sell |
14,249
-353
| -2% | -$121K | 0.08% | 153 |
|
|
2026
Q1 | $5.14M | Buy |
14,602
+493
| +3% | +$176K | 0.09% | 141 |
|
|
2025
Q4 | $4.62M | Buy |
14,109
+661
| +5% | +$210K | 0.08% | 141 |
|
|
2025
Q3 | $3.8M | Buy |
13,448
+2,796
| +26% | +$811K | 0.06% | 156 |
|
|
2025
Q2 | $2.97M | Sell |
10,652
-121
| -1% | -$34.3K | 0.05% | 172 |
|
|
2025
Q1 | $3.36M | Buy |
10,773
+288
| +3% | +$85K | 0.06% | 157 |
|
|
2024
Q4 | $2.73M | Sell |
10,485
-30
| -0.3% | -$8.9K | 0.05% | 165 |
|
|
2024
Q3 | $3.39M | Buy |
10,515
+55
| +0.5% | +$18K | 0.06% | 147 |
|
|
2024
Q2 | $3.27M | Buy |
10,460
+1,312
| +14% | +$385K | 0.07% | 146 |
|
|
2024
Q1 | $2.6M | Buy |
9,148
+136
| +2% | +$39.8K | 0.06% | 152 |
|
|
2023
Q4 | $2.6M | Buy |
9,012
+82
| +0.9% | +$22.3K | 0.06% | 149 |
|
|
2023
Q3 | $2.4M | Buy |
8,930
+1,253
| +16% | +$313K | 0.06% | 145 |
|
|
2023
Q2 | $1.7M | Buy |
7,677
+1,217
| +19% | +$282K | 0.05% | 115 |
|
|
2023
Q1 | $1.56M | Buy |
6,460
+1,995
| +45% | +$490K | 0.05% | 121 |
|
|
2022
Q4 | $1.17M | Buy |
4,465
+64
| +1% | +$17.2K | 0.04% | 131 |
|
|
2022
Q3 | $992K | Buy |
4,401
+144
| +3% | +$34.9K | 0.04% | 140 |
|
|
2022
Q2 | $1.04M | Buy |
4,257
+201
| +5% | +$49.3K | 0.03% | 146 |
|
|
2022
Q1 | $981K | Buy |
4,056
+111
| +3% | +$25.5K | 0.03% | 156 |
|
|
2021
Q4 | $888K | Buy |
3,945
+121
| +3% | +$25.5K | 0.02% | 172 |
|
|
2021
Q3 | $813K | Sell |
3,824
-147
| -4% | -$33.8K | 0.02% | 164 |
|
|
2021
Q2 | $968K | Sell |
3,971
-134
| -3% | -$33K | 0.03% | 157 |
|
|
2021
Q1 | $1.02M | Sell |
4,105
-601
| -13% | -$143K | 0.03% | 152 |
|
|
2020
Q4 | $1.08M | Buy |
4,706
+62
| +1% | +$14.3K | 0.04% | 141 |
|
|
2020
Q3 | $1.18M | Sell |
4,644
-55
| -1% | -$13.6K | 0.04% | 119 |
|
|
2020
Q2 | $1.11M | Buy |
4,699
+47
| +1% | +$10.7K | 0.04% | 117 |
|
|
2020
Q1 | $943K | Buy |
4,652
+95
| +2% | +$20.8K | 0.05% | 116 |
|
|
2019
Q4 | $1.1M | Sell |
4,557
-160
| -3% | -$35.3K | 0.04% | 132 |
|
|
2019
Q3 | $913K | Sell |
4,717
-345
| -7% | -$66.2K | 0.04% | 134 |
|
|
2019
Q2 | $933K | Buy |
5,062
+1,546
| +44% | +$277K | 0.04% | 133 |
|
|
2019
Q1 | $668K | Buy |
3,516
+194
| +6% | +$37K | 0.05% | 96 |
|
|
2018
Q4 | $647K | Buy |
3,322
+208
| +7% | +$40.6K | 0.05% | 93 |
|
|
2018
Q3 | $646K | Sell |
3,114
-29
| -0.9% | -$5.71K | 0.05% | 93 |
|
|
2018
Q2 | $615K | Sell |
3,143
-75
| -2% | -$13.3K | 0.04% | 93 |
|
|
2018
Q1 | $549K | Sell |
3,218
-353
| -10% | -$64.8K | 0.04% | 98 |
|
|
2017
Q4 | $621K | Buy |
3,571
+344
| +11% | +$60.9K | 0.05% | 95 |
|
|
2017
Q3 | $602K | Sell |
3,227
-115
| -3% | -$20.4K | 0.05% | 95 |
|
|
2017
Q2 | $583K | Buy |
3,342
+131
| +4% | +$21.3K | 0.05% | 95 |
|
|
2017
Q1 | $525K | Buy |
3,211
+606
| +23% | +$101K | 0.05% | 98 |
|
|
2016
Q4 | $381K | Buy |
2,605
+160
| +7% | +$24.1K | 0.04% | 107 |
|
|
2016
Q3 | $408K | Sell |
2,445
-25
| -1% | -$4.23K | 0.05% | 82 |
|
|
2016
Q2 | $376K | Hold |
2,470
| – | – | 0.05% | 93 |
|
|
2016
Q1 | $370K | Sell |
2,470
-60
| -2% | -$8.91K | 0.04% | 99 |
|
|
2015
Q4 | $411K | Sell |
2,530
-15
| -0.6% | -$2.36K | 0.05% | 105 |
|
|
2015
Q3 | $352K | Sell |
2,545
-75
| -3% | -$11.8K | 0.05% | 104 |
|
|
2015
Q2 | $402K | Hold |
2,620
| – | – | 0.05% | 95 |
|
|
2015
Q1 | $419K | Sell |
2,620
-117
| -4% | -$18.4K | 0.06% | 87 |
|
|
2014
Q4 | $436K | Hold |
2,737
| – | – | 0.07% | 84 |
|
|
2014
Q3 | $384K | Hold |
2,737
| – | – | 0.06% | 84 |
|
|
2014
Q2 | $324K | Buy |
2,737
+165
| +6% | +$19.1K | 0.05% | 89 |
|
|
2014
Q1 | $317K | Sell |
2,572
-900
| -26% | -$109K | 0.05% | 94 |
|
|
2013
Q4 | $396K | Buy |
3,472
+770
| +28% | +$87.6K | 0.06% | 87 |
|
|
2013
Q3 | $302K | Buy |
2,702
+650
| +32% | +$70.5K | 0.05% | 96 |
|
|
2013
Q2 | $202K | Buy |
+2,052
| New | +$213K | 0.04% | 123 |
|
Other funds holding AMGN
Crestwood Advisors Group's AMGN Position: Q2 2026 in Review
Crestwood Advisors Group reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $121K and leaving 14,249 shares worth $5.16M. The position accounts for 0.08% of the portfolio, ranked #153.
Crestwood Advisors Group first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Crestwood Advisors Group held 14,249 shares of Amgen worth $5.16M as of Q2 2026.
- Crestwood Advisors Group sold 353 Amgen shares in Q2 2026, an estimated $121K.
- Amgen made up 0.08% of Crestwood Advisors Group's portfolio in Q2 2026, its #153 holding.
- Crestwood Advisors Group first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.